Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenetic Biosciences Inc

2.79
+0.09743.61%
Post-market: 2.860.0676+2.42%16:00 EDT
Volume:7.45K
Turnover:20.93K
Market Cap:4.31M
PE:-1.09
High:2.86
Open:2.83
Low:2.68
Close:2.70
Loading ...
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 23, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Oct 08, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 30, 2019

Major Issues Report

Current report, item 5.02
Sep 19, 2019

Correspondence

[Cover]Correspondence
Sep 09, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 04, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Aug 15, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 29, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 29, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Jul 25, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 22, 2019

Major Issues Report

Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01
Jul 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jul 16, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Jul 16, 2019

Major Issues Report

Current report, item 9.01
Oct 31, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Oct 31, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Oct 31, 2016

[Amend]Public Prospectus

初始注册新的证券——修改